How confident are we really in anti-Xa monitoring

Between analytical limitations in complex ECMO patients and delays in turnaround time, there is a growing need to rethink how we monitor anticoagulation and fibrinolysis at the bedside.

🇦🇺 Here in Australia, there is an exciting opportunity to advance this field through collaborative research using hashtag#Multiclot viscoelastic assays, including to better understand real-time coagulation dynamics and support more individualized anticoagulation strategies in ECMO.

If you're an intensivist, perfusionist, or researcher interested in innovation in ECMO haemostasis monitoring, we’d love to connect and explore potential collaborations.